DP-b99 acute stroke study - Pilot Study

Completed

Phase N/A Results

Summary of Purpose

To reconfirm the efficacy, safety data, and beneficial effect of DP-b99 previously observed in stroke patients.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 18 March 2009.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • D-Pharm Ltd, Israel.

Trial Design

Double-blind, randomized, placebo controlled, tolerability trial.

Contacts

Not available